Skip to content

AACR Annual Meeting 2026

April 17–22, 2026 · San Diego · 2418 items

After the meeting

The rest: ovarian, HNSCC, GBM and other floor tumors

26 people · 28 posts9 topics

Start here

The nine chapters above are the written recap. This cell is what they did not claim, but people were still posting: ovarian, head and neck, GBM, prostate, liver, gastroesophageal, plus MYC and TP53.

One cell because they do not each carry a chapter — not because they can be dropped. Open it to see who was still on the floor.

Ovarian and gyn tags (#OVARIANCANCER, #GYNCSM, #HNSCC) had trial abstracts on the floor, but not a written chapter the way lung and breast did. GBM, prostate, liver and gastroesophageal are the same: people were posting, the recap did not open a direction.

MYC and TP53 are genes that cut across tumors; hanging them under KRAS or lung would be a misfile. They sit here to mark that they showed up, without forcing a chapter.

Analysis

The rest is not a dump. Hallway hashtags are already off the page; what remains has people, posts, or abstracts. If one of these grows into a spine at the next meeting, it gets its own direction.

Still open
  • Whether ovarian or HNSCC has a readout thick enough to become its own direction.
  • Whether the MYC / TP53 talk actually belongs back under resistance or systems biology.

Floor

Apr 23Thu
Apr 22Wed
Apr 21Tue
Apr 20Mon
Apr 19Sun
Apr 18Sat

Other directions

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org